PH14216A - Polyene compounds and pharmaceutical compositions - Google Patents

Polyene compounds and pharmaceutical compositions

Info

Publication number
PH14216A
PH14216A PH21098A PH21098A PH14216A PH 14216 A PH14216 A PH 14216A PH 21098 A PH21098 A PH 21098A PH 21098 A PH21098 A PH 21098A PH 14216 A PH14216 A PH 14216A
Authority
PH
Philippines
Prior art keywords
pharmaceutical compositions
polyene compounds
polyene
compounds
pharmaceutical
Prior art date
Application number
PH21098A
Other languages
English (en)
Inventor
P Loeliger
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of PH14216A publication Critical patent/PH14216A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C29/00Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
    • C07C29/132Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group
    • C07C29/136Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group of >C=O containing groups, e.g. —COOH
    • C07C29/143Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group of >C=O containing groups, e.g. —COOH of ketones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C33/00Unsaturated compounds having hydroxy or O-metal groups bound to acyclic carbon atoms
    • C07C33/38Alcohols containing six-membered aromatic rings and other rings and having unsaturation outside the aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C33/00Unsaturated compounds having hydroxy or O-metal groups bound to acyclic carbon atoms
    • C07C33/40Halogenated unsaturated alcohols
    • C07C33/50Halogenated unsaturated alcohols containing six-membered aromatic rings and other rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/45Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by condensation
    • C07C45/46Friedel-Crafts reactions
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/76Ketones containing a keto group bound to a six-membered aromatic ring
    • C07C49/782Ketones containing a keto group bound to a six-membered aromatic ring polycyclic
    • C07C49/792Ketones containing a keto group bound to a six-membered aromatic ring polycyclic containing rings other than six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/54Quaternary phosphonium compounds
    • C07F9/5456Arylalkanephosphonium compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00Systems containing two condensed rings
    • C07C2602/02Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04One of the condensed rings being a six-membered aromatic ring
    • C07C2602/10One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PH21098A 1977-05-04 1978-05-03 Polyene compounds and pharmaceutical compositions PH14216A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
LU77254A LU77254A1 (en, 2012) 1977-05-04 1977-05-04

Publications (1)

Publication Number Publication Date
PH14216A true PH14216A (en) 1981-04-02

Family

ID=19728555

Family Applications (1)

Application Number Title Priority Date Filing Date
PH21098A PH14216A (en) 1977-05-04 1978-05-03 Polyene compounds and pharmaceutical compositions

Country Status (32)

Country Link
US (1) US4193931A (en, 2012)
JP (1) JPS53137940A (en, 2012)
AR (1) AR220704A1 (en, 2012)
AT (1) AT356647B (en, 2012)
AU (1) AU522598B2 (en, 2012)
BE (1) BE866651A (en, 2012)
BR (1) BR7802807A (en, 2012)
CA (1) CA1114830A (en, 2012)
CH (2) CH641755A5 (en, 2012)
CS (1) CS214853B2 (en, 2012)
CU (1) CU21105A (en, 2012)
DE (1) DE2819213A1 (en, 2012)
DK (1) DK155730C (en, 2012)
ES (2) ES469394A1 (en, 2012)
FI (1) FI66587C (en, 2012)
FR (1) FR2390428A1 (en, 2012)
GB (2) GB1600914A (en, 2012)
GR (1) GR74426B (en, 2012)
HU (1) HU183088B (en, 2012)
IE (1) IE46946B1 (en, 2012)
IL (2) IL54590A (en, 2012)
IT (1) IT1096278B (en, 2012)
LU (1) LU77254A1 (en, 2012)
MC (1) MC1193A1 (en, 2012)
MY (1) MY8500250A (en, 2012)
NL (1) NL7804773A (en, 2012)
NO (1) NO148290C (en, 2012)
NZ (1) NZ187114A (en, 2012)
PH (1) PH14216A (en, 2012)
PT (1) PT67988B (en, 2012)
SE (1) SE436644B (en, 2012)
ZA (1) ZA782415B (en, 2012)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4216312A (en) * 1978-08-24 1980-08-05 Hoffmann-La Roche Inc. Furyl substituted polyenes
FI67386C (fi) * 1979-06-21 1985-03-11 Hoffmann La Roche Foerfarande foer framstaellning av nya terapeutiskt anvaendbara sockerderivat
CH651007A5 (de) * 1982-06-24 1985-08-30 Hoffmann La Roche Polyenverbindungen.
DK158947C (da) * 1982-07-06 1991-01-21 Hoffmann La Roche Tetrahydronaphthalin-,benzofuran- og benzothiophenderivater, fremstilling og anvendelse deraf samt rodenticid indeholdende saadanne derivater
US4529600A (en) * 1982-09-09 1985-07-16 Sri International Pentadeuterioretinoids
US4439614A (en) * 1982-09-22 1984-03-27 Sri International 5,6-Methano-5,6-dihydroretinoids
US4464389A (en) * 1982-10-20 1984-08-07 Sri International Esters of retinoic acid and pentaerythritol and monobenzal acetals thereof
US4539154A (en) * 1983-06-15 1985-09-03 Hoffmann-La Roche Inc. Polyene compounds
CH661516A5 (de) * 1983-12-08 1987-07-31 Hoffmann La Roche Phenylnonatetraenoylzuckerderivate.
US4783549A (en) * 1984-09-05 1988-11-08 L'oreal Benzonorbornene derivatives, processes for their preparation and medicinal and cosmetic compositions containing them
FR2580277B1 (fr) * 1985-04-15 1988-06-10 Oreal Nouveaux derives naphtaleniques a action retinoique, le ur procede de preparation et compositions medicamenteuse et cosmetique les contenant
US5030764A (en) * 1986-05-23 1991-07-09 Hoffmann-La Roche Inc. Novel tetrahydronaphthalene and indane derivatives
US5030765A (en) * 1986-05-23 1991-07-09 Hoffmann-La Roche Inc. Novel tetrahydronaphthalene and indane derivatives
ZW7487A1 (en) * 1986-05-23 1987-12-16 Hoffmann La Roche Tetrahydronaphthaline and indane derivatives
AT388728B (de) * 1987-03-17 1989-08-25 Hoffmann La Roche Neue tetrahydronaphthalin- und indanderivate
US5250562A (en) * 1988-02-24 1993-10-05 Hoffmann-La Roche Inc. Stilbene derivatives
US5248696A (en) * 1991-04-18 1993-09-28 World Research Institute For Science And Technology, Inc. Composition and method for treating tumors
US5780676A (en) * 1992-04-22 1998-07-14 Ligand Pharmaceuticals Incorporated Compounds having selective activity for Retinoid X Receptors, and means for modulation of processes mediated by Retinoid X Receptors
US7655699B1 (en) 1992-04-22 2010-02-02 Eisai Inc. Compounds having selective activity for retinoid X receptors, and means for modulation of processes mediated by retinoid X receptors
CA2129773C (en) * 1993-09-02 2007-05-01 Michael Klaus Aromatic carboxylic acid derivatives
FR2719041B1 (fr) * 1994-04-26 1996-05-31 Cird Galderma Nouveaux composés polyéniques, compositions pharmaceutiques et cosmétiques les contenant et utilisations.
DK0800503T3 (da) * 1994-12-30 2000-08-07 Ligand Pharm Inc Hidtil ukendte trien-retinoidforbindelser og fremgangsmåder
US7115728B1 (en) * 1995-01-30 2006-10-03 Ligand Pharmaceutical Incorporated Human peroxisome proliferator activated receptor γ
DE69627193T2 (de) 1995-10-06 2004-01-29 Ligand Pharm Inc Dimer-selektive rxr modulatoren und verfahren zu ihrer verwendung
US6112489A (en) * 1995-12-12 2000-09-05 Monotech International, Inc. Monocoque concrete structures
WO1998007716A2 (en) * 1996-08-23 1998-02-26 The Board Of Regents For Oklahoma State University Heteroarotinoids-anticancer agents with receptor specificity and tgase activity
FR2752837B1 (fr) * 1996-09-02 1999-11-12 Cird Galderma Nouveaux composes modulateurs des recepteurs hormonaux, les compositions les comprenant et leur utilisation en therapie
AU8588798A (en) * 1997-07-25 1999-02-16 Institut Pasteur Human peroxisome proliferator activated receptor gamma (ppargamma) gene re gulatory sequences and uses therefor
FR2768731B1 (fr) * 1997-09-25 1999-12-10 Cird Galderma Derives insatures en position -4 du 6-tert-butyl-1,1- dimethylindane et leur utilisation en medecine humaine ou veterinaire ainsi qu'en cosmetique
US6534545B1 (en) 1997-09-25 2003-03-18 Galderma Research & Development Unsaturated derivatives at the 4-position of 6-tert-butyl-1,1-dimethylindane and their use in human and veterinary medicine and cosmetics
JP2003520758A (ja) * 1998-06-12 2003-07-08 リガンド・ファーマシューティカルズ・インコーポレイテッド 抗エストロゲン耐性乳癌のrxrモジュレーターを用いた処置
US6566372B1 (en) * 1999-08-27 2003-05-20 Ligand Pharmaceuticals Incorporated Bicyclic androgen and progesterone receptor modulator compounds and methods
PL353792A1 (en) * 1999-08-27 2003-12-01 Ligand Pharmaceuticals Incorporatedligand Pharmaceuticals Incorporated Androgen receptor modulator compounds and methods
US6667313B1 (en) 1999-08-27 2003-12-23 Ligand Pharmaceuticals Inc. 8-substituted-6-triflouromethyl-9-pyrido [3,2-G] quinoline compounds as androgen receptor modulators
CA2383565A1 (en) * 1999-09-14 2001-03-22 Ligand Pharmaceuticals Incorporated Rxr modulators with improved pharmacologic profile
US8026280B2 (en) 2001-03-27 2011-09-27 Errant Gene Therapeutics, Llc Histone deacetylase inhibitors
US7312247B2 (en) 2001-03-27 2007-12-25 Errant Gene Therapeutics, Llc Histone deacetylase inhibitors
US7842727B2 (en) * 2001-03-27 2010-11-30 Errant Gene Therapeutics, Llc Histone deacetylase inhibitors
US6495719B2 (en) * 2001-03-27 2002-12-17 Circagen Pharmaceutical Histone deacetylase inhibitors
US6586460B1 (en) 2001-04-02 2003-07-01 The Board Of Regents For Oklahoma State University Heteroarotinoids containing urea or thiourea linker
AU2003243272A1 (en) * 2002-05-22 2003-12-12 Errant Gene Therapeutics, Llc Histone deacetylase inhibitors based on alpha-ketoepoxide compounds
EP1567142A4 (en) * 2002-11-20 2005-12-14 Errant Gene Therapeutics Llc TREATMENT OF PULMONARY CELLS WITH HISTONE DEACETYLASE INHIBITORS
US9050310B2 (en) * 2004-06-25 2015-06-09 Minas Theodore Coroneo Treatment of ocular lesions
WO2006052916A2 (en) * 2004-11-08 2006-05-18 Errant Gene Therapeutics, Inc. Histone deacetylase inhibitors
US20060204474A1 (en) * 2005-02-25 2006-09-14 Coroneo Minas T Treatment of epithelial layer lesions
WO2012076842A1 (en) * 2010-12-09 2012-06-14 University Of Durham Synthetic retinoids for control of cell differentiation
US11045441B2 (en) 2015-10-13 2021-06-29 Wisconsin Alumni Research Foundation Use of retinoic acid and analogs thereof to treat central neural apneas
AU2018341099B2 (en) * 2017-09-28 2023-11-02 Kenvue Brands Llc Cosmetic compositions and method of treating the skin
US11197841B2 (en) 2019-07-23 2021-12-14 Johnson & Johnson Surgical Vision, Inc. Compositions and methods for treating the eye
CA3107707A1 (en) 2018-07-27 2020-01-30 Johnson & Johnson Surgical Vision, Inc. Compositions and methods for treating the eye
US10966948B2 (en) 2019-07-23 2021-04-06 Johnson & Johnson Surgical Vision, Inc. Compositions and methods for treating the eye
US20200030226A1 (en) 2018-07-27 2020-01-30 Johnson & Johnson Consumer Inc. Botanical and bacterial extracts displaying retinol-like activity
US11969454B2 (en) 2019-11-19 2024-04-30 Johnson & Johnson Surgical Vision, Inc. Compositions and methods for treating the eye

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3452085A (en) * 1966-02-11 1969-06-24 Carbo Erba Spa Alpha-(5-indanyl)-butyric acid
US3781314A (en) * 1971-07-14 1973-12-25 Hoffmann La Roche Polyene compounds
BE793108A (fr) * 1971-12-22 1973-06-21 Hoffmann La Roche Derives polyeniques
DE2431198C2 (de) * 1973-07-02 1987-04-30 Takeda Chemical Industries, Ltd., Osaka Chinonderivate und sie enthaltende pharmazeutische Zubereitungen
CH582668A5 (en, 2012) * 1973-08-10 1976-12-15 Hoffmann La Roche
CH585709A5 (en, 2012) * 1973-08-24 1977-03-15 Hoffmann La Roche
CH592598A5 (en, 2012) * 1973-10-30 1977-10-31 Hexachimie
AR206620A1 (es) * 1974-02-07 1976-08-06 Hexachimie Procedimiento para preparar acidos 5-indanilaceticos
FR2276035A1 (fr) * 1974-06-28 1976-01-23 Lipha Nouveaux derives de l'indane
US4054589A (en) * 1974-09-26 1977-10-18 Hoffmann-La Roche Inc. Novel 9-substituted phenyl-3,7-dimethyl-nona-2,4,6,8-tetraene esters
JPS51125235A (en) * 1974-09-26 1976-11-01 Hoffmann La Roche Preparation of polyene compounds

Also Published As

Publication number Publication date
IE46946B1 (en) 1983-11-16
PT67988A (en) 1978-06-01
CH641755A5 (de) 1984-03-15
GB1600915A (en) 1981-10-21
CS214853B2 (en) 1982-06-25
DK155730B (da) 1989-05-08
DE2819213C2 (en, 2012) 1987-09-24
SE7805136L (sv) 1978-11-05
FI781227A7 (fi) 1978-11-05
AR220704A1 (es) 1980-11-28
IL54590A (en) 1982-02-28
MY8500250A (en) 1985-12-31
BR7802807A (pt) 1979-01-02
HU183088B (en) 1984-04-28
JPS6332777B2 (en, 2012) 1988-07-01
AT356647B (de) 1980-05-12
BE866651A (fr) 1978-11-03
DK195378A (da) 1978-11-05
FI66587C (fi) 1984-11-12
IE780864L (en) 1978-11-04
GB1600914A (en) 1981-10-21
CA1114830A (en) 1981-12-22
ES475240A1 (es) 1979-05-16
IL54590A0 (en) 1978-07-31
CH642380A5 (de) 1984-04-13
IL61697A0 (en) 1981-01-30
DK155730C (da) 1989-10-02
NO148290C (no) 1983-09-14
GR74426B (en, 2012) 1984-06-28
IT7823003A0 (it) 1978-05-04
US4193931A (en) 1980-03-18
FR2390428B1 (en, 2012) 1983-03-04
MC1193A1 (fr) 1979-02-23
SE436644B (sv) 1985-01-14
NL7804773A (nl) 1978-11-07
PT67988B (en) 1980-05-05
NO781586L (no) 1978-11-07
CU21105A (es) 1981-12-04
ZA782415B (en) 1979-04-25
AU3576278A (en) 1979-11-08
IT1096278B (it) 1985-08-26
ES469394A1 (es) 1979-02-01
NZ187114A (en) 1980-11-14
FR2390428A1 (fr) 1978-12-08
ATA320478A (de) 1979-10-15
AU522598B2 (en) 1982-06-17
DE2819213A1 (de) 1978-11-16
JPS53137940A (en) 1978-12-01
NO148290B (no) 1983-06-06
LU77254A1 (en, 2012) 1979-01-18
FI66587B (fi) 1984-07-31

Similar Documents

Publication Publication Date Title
PH14216A (en) Polyene compounds and pharmaceutical compositions
ZA781398B (en) Pharmaceutical compositions
SG34985G (en) Pharmaceutical compositions
GB2003028B (en) Pharmaceutical compositions
JPS53109934A (en) Pharmaceutical composition
JPS5484022A (en) Pharmaceutical composition
JPS5449333A (en) Pharmaceutical composition
JPS53133637A (en) Pharmaceutical composition
PH15193A (en) Pharmaceutical composition
GB2008403B (en) Pharmaceutical compositions
GB2002229B (en) Pharmaceutical composition
GB2021409B (en) Pharmaceutical composition
MW478A1 (en) Pharmaceutical compositions
NZ186689A (en) Substituted bis-benzimidazolyl compounds and pharmaceutical compositions
JPS5394038A (en) Pharmaceutical composition
IL54220A0 (en) Pharmaceutical compositions comprising trans-broparestrol
NZ186334A (en) Oxadiazolopyrimidines:pharmaceutical compositions
ZA78387B (en) Pharmaceutical compositions
GB2008408B (en) Pharmaceutical compositions
ZA7812B (en) Pharmaceutical compositions
JPS545045A (en) Pharmaceutical composition
ZA782736B (en) Pharmaceutical compositions
GB1556851A (en) Pharmaceutical compositions
JPS542338A (en) Pharmaceutical composition
GB2006010B (en) Pharmaceutical compositions